Restaking · $1B TVL. Symbiotic is the permissionless challenger to EigenLayer's restaking monopoly — a deliberately minimal, asset-agnostic shared-security marketplace backed by prominent venture capital. The screen catches it pre-revenue: an architecture bet still funded by emissions and expectation.
Solvency screens at B, the weakest in the universe alongside Babylon's cohort. A 0.3x sustainability ratio means the protocol spends multiples of what it earns, ~18% of supply unlocks within the year, and TVL is down 30% from its points-era peak. The contracts are lean; the economics are not yet an economy.
Legitimacy screens at BBB: a strong technical team and reasonable audit posture, with delivery (6/10) trailing the original roadmap and governance (4/10) still effectively teamside. The flexibility-first design is intellectually credible but young.
Growth screens at B. Twelve percent category share is meaningful as a challenger, but the tide that lifted restaking has ebbed, and momentum without a fee market is just emissions in motion.
Composite B. A well-built option on the same unproven thesis as its rival, minus the first-mover cushion. The screen's watch item is identical to EigenLayer's — real security-budget revenue — with less runway for it to arrive.
"A chain is as strong as its weakest link." The conservative composite takes the weakest dimension and inherits any notching cap, so a single structural weakness cannot be diluted by strength elsewhere.
